Accueil › Colite ulcéreuse › Colorado › Colorado Springs
Essais cliniques pour Colite ulcéreuse à Colorado Springs, CO
14 études pour Colite ulcéreuse recherchent des participants dans et autour de Colorado Springs (dans un rayon d'environ 30 miles). Ouvrez une étude pour voir qui peut participer et comment contacter l'équipe.
Texte officiel de l'étude (anglais)
Vous recrutez pour une étude ? Mettez-la en avant en haut de cette page — $99 pour 30 jours →
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
Recrutement en coursPhase 2
- Peak Gastroenterology Associates - Colorado Springs - North Cascade Avenue /ID# 280507, Colorado Springs
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
Recrutement en coursPhase 4
- Peak Gastroenterology Associates, Colorado Springs
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
Recrutement en coursPhase 2
- Peak Gastroenterology Associates, Colorado Springs
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
Recrutement en coursPhase 2
- Site 033, Colorado Springs
A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)
Recrutement en coursPhase 2
- Peak Gastroenterology Associates ( Site 1052), Colorado Springs
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
Recrutement en coursPhase 2
- Peak Gastroenterology Associates, Colorado Springs
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
Recrutement en coursPhase 3
- Peak Gastroenterology Associates, Colorado Springs
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
Recrutement en coursPhase 2
- Peak Gastroenterology Associates, Colorado Springs
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Recrutement en coursPhase 2
- Peak Gastroenterology Associates, Colorado Springs
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Recrutement en coursPhase 3
- Peak Gastroenterology Associates - Colorado Springs - Site Number: 8400039, Colorado Springs
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
Recrutement en coursPhase 3
- Peak Gastroenterology Associates, Colorado Springs
A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis
Recrutement en coursPhase 2
- Peak Gastroenterology Associates, Colorado Springs
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Recrutement en coursPhase 3
- Peak Gastroenterology Associates - Colorado Springs - Site Number: 8400039, Colorado Springs
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
Recrutement en coursPhase 2
- Mirador Therapeutics Selected Site, Colorado Springs
Essais pour Colite ulcéreuse dans d'autres villes
- New York City, NY23 études
- Orlando, FL22 études
- Miami, FL21 études
- Houston, TX17 études
- San Antonio, TX16 études
- Chicago, IL15 études
- Tacoma, WA15 études
- San Diego, CA15 études
- Tyler, TX14 études
- Los Angeles, CA13 études
- St. Louis, MO13 études
- Washington, DC12 études
Autres études à Colorado Springs
- Maladie de Crohn13 études
- Cancer de la prostate12 études
- Cancer du poumon non à petites cellules11 études
- Cancer du poumon8 études
- Cancer du sein7 études
- Asthme6 études
- Cancer colorectal6 études
- Cancer du côlon6 études
- Carcinome épidermoïde de la tête et du cou4 études
- Mélanome4 études
- Cancer rectal4 études
- Maladie inflammatoire chronique de l'intestin4 études
Source : ClinicalTrials.gov, données récupérées le 5 oct. 2026. Chaque étude définit ses propres critères d'éligibilité ; l'équipe de l'étude décide qui peut y participer.